Suginami-ku, Japan Clinical Trials

A listing of Suginami-ku, Japan clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 25 clinical trials
Efficacy and Safety of Pembrolizumab (MK-3475) Plus Enzalutamide Plus Androgen Deprivation Therapy (ADT) Versus Placebo Plus Enzalutamide Plus ADT in Participants With Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) (MK-3475-991/KEYNOTE-991)

This study will assess the efficacy and safety of pembrolizumab plus enzalutamide plus ADT versus placebo plus enzalutamide plus ADT in participants with mHSPC. The primary hypothesis is that in participants with mHSPC, the combination of pembrolizumab plus enzalutamide plus ADT is superior to placebo plus enzalutamide plus ADT with …

Tokyo Women's Medical University Hospital ( Site 0739)
 (4.7 away) Contact site
  • 272 views
  • 16 Jun, 2021
  • +222 other locations
Oral Islatravir (MK-8591) Once-Monthly as Preexposure Prophylaxis (PrEP) in Men and Transgender Women Who Have Sex With Men and Are at High Risk for HIV-1 Infection (MK-8591-024)

The main purpose of the study is to evaluate the efficacy and safety of oral Islatravir (ISL) once monthly (QM) as Preexposure Prophylaxis (PrEP) in cisgender men who have sex with men (MSM) and transgender women (TGW) who have sex with men and who are at high risk of HIV-1 …

Center Hospital of the National Center for Global Health and Medicine ( Site 0101)
 (4.5 away) Contact site
  • 0 views
  • 03 Jun, 2021
  • +13 other locations
A Study to Assess the Safety and Tolerability of E8001 in Healthy Male Participants

The purpose of this study is to evaluate the safety, tolerability, and pharmacokinetics (PK) of E8001 of single ascending dose intravenous infusions in healthy male participants.

Eisai Trial Site #1
 (7.0 away) Contact site
  • 0 views
  • 02 Jun, 2021
  • 1 location
A Study of JNJ-67953964 in Healthy Japanese Adult Male Participants

The purpose of this study is to evaluate the safety, tolerability, and pharmacokinetics (PK) after single- and multiple-dose oral administration of JNJ-67953964 in healthy Japanese adult male participants.

Sumida Hospital
 (9.2 away) Contact site
  • 0 views
  • 22 May, 2021
  • 1 location
A Study in Healthy Japanese Men to Test How Well Different Doses of BI 764198 Are Tolerated

The main objectives of this trial are to investigate safety and tolerability of BI 764198 in healthy male subjects following oral administration of single dose and multiple rising doses per day over 14 days. Secondary objectives are the exploration of pharmacokinetics (PK) of BI 764198 after single and multiple oral …

SOUSEIKAI Sumida Hospital
 (9.2 away) Contact site
  • 0 views
  • 16 Jun, 2021
  • 1 location
A Study in Healthy Japanese Men to Test How Different Doses of BI 1323495 Are Tolerated and How Itraconazole Influences the Amount of BI 1323495 in the Blood

The main objective of the single-rising dose (SRD) part and the multiple rising dose (MD) part is to investigate safety, tolerability, pharmacokinetics and pharmacodynamics (for MD part only) following single rising doses and multiple oral doses of BI 1323495 in healthy male Japanese subjects genotyped as poor metabolizers (PM) and …

SOUSEIKAI Sumida Hospital
 (9.2 away) Contact site
  • 0 views
  • 16 Jun, 2021
  • 1 location
Safety and Efficacy of Nonacog Beta Pegol (N9-GP) in Previously Untreated Patients With Haemophilia B

This trial is conducted globally. The aim of the trial is to investigate the safety and efficacy of nonacog beta pegol (N9-GP) in previously untreated patients with Haemophilia B.

factor ix
hemophilia
blood components
coagulation factors
coagulation factor
Novo Nordisk Investigational Site
 (2.1 away) Contact site
  • 379 views
  • 15 Mar, 2021
  • +74 other locations
Study of Pembrolizumab (MK-3475) Plus Olaparib Versus Abiraterone Acetate or Enzalutamide in Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-7339-010/KEYLYNK-010)

The purpose of this study is to assess the efficacy and safety of the combination of the polyadenosine 5'-diphosphoribose poly(ADP-ribose) polymerase (PARP) inhibitor olaparib and pembrolizumab in the treatment of participants with mCRPC who have failed to respond to either abiraterone acetate or enzalutamide (but not both) and to chemotherapy. …

androgen suppression
prednisone
adenocarcinoma of prostate
antiandrogen therapy
docetaxel
Keio University Hospital ( Site 0710)
 (4.7 away) Contact site
  • 394 views
  • 16 Jun, 2021
  • +212 other locations
Long-term Safety and Efficacy Study of Fitusiran in Patients With Hemophilia A or B With or Without Inhibitory Antibodies to Factor VIII or IX

Primary Objective: To characterize the long-term safety and tolerability of fitusiran Secondary Objectives: To characterize the long-term efficacy of fitusiran as assessed by the frequency of: Bleeding episodes Spontaneous bleeding episodes Target joint bleeding episodes To characterize the effects of fitusiran on health-related quality of life (HRQOL) measures in participants …

hemarthrosis
antihemophilic factor
severe haemophilia a
fitusiran
Investigational Site Number 3920008
 (1.8 away) Contact site
  • 180 views
  • 12 Mar, 2021
  • +65 other locations
Research Study to Look at How Well the Drug Concizumab Works in Your Body if You Have Haemophilia Without Inhibitors

This study will test how well a new medicine called concizumab works in the body of people with haemophilia A or B without inhibitors. The purpose is to show that concizumab can prevent bleeds in the body and is safe to use. Participants who usually only take medicine to treat …

Novo Nordisk Investigational Site
 (4.7 away) Contact site
  • 36 views
  • 17 Jun, 2021
  • +103 other locations